Orogen, Chemspace & Enamine Partner on AI-Driven DEL Libraries
– Partnering supports novel DEL-screening capabilities – Chemspace/Enamine positioned to augment product and service offerings – Orogen to gain potential novel therapeutic small molecules Orogen Therapeutics, Inc., a private drug discovery company utilizing its proprietary, AI-enabled DNA encoded library (DEL) technology to identify novel chemical matter against medically and commercially attractive drug targets, Chemspace, LLC, an expert in…
